GRP78-derived peptide for identifying high-efficiency stem cells

US11760792B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11760792-B2
Application numberUS-201816755373-A
CountryUS
Kind codeB2
Filing dateOct 15, 2018
Priority dateOct 13, 2017
Publication dateSep 19, 2023
Grant dateSep 19, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a GRP78-derived peptide for screening highly efficient stem cells and the use thereof, and more particularly, to screening highly efficient stem cells using, as a marker, a GRP78-derived peptide capable of binding to the binding domain of GRP78 protein on the cell surface. According to the present invention, the GRP78-derived peptide comprising only a specific amino acid sequence capable of recognizing highly efficient stem cells, among the amino acid sequence of GRP78, makes it possible to screen only non-senescent young stem cells. In addition, when stem cells are treated with the GRP78-derived peptide or the GRP78-derived peptide is introduced into stem cells, the efficiency of the stem cells can be increased. Thus, the GRP78-derived peptide is useful for the production of stem cell therapy products having excellent efficacy.

First claim

Opening claim text (preview).

The invention claimed is: 1. A peptide consisting of the amino acid sequence of SEQ ID NO: 14. 2. The peptide of claim 1 , wherein the peptide is derived from Glucose-regulated protein 78 (GRP78). 3. The peptide of claim 1 , wherein the peptide of SEQ ID NO: 14 binds ATP, which is regulated by GRP78. 4. A method of screening highly efficient stem cells that express GRP78, comprising steps of: (a) conjugating a fluorescent label to a peptide that binds GRP78 and consists of the amino acid sequence of SEQ ID NO: 14; (b) culturing the fluorescent labeled-conjugated peptide with stem cells to allow binding of the fluorescent labeled-conjugated peptide with stem cells that express GRP78; and (c) screening for GRP78-expressing stem cells under a fluorescence microscope. 5. A composition comprising the peptide of claim 1 . 6. A kit comprising the peptide of claim 1 . 7. A method of increasing efficiency of stem cells that express GRP78 comprising treating stem cells that express GRP78 with the peptide of claim 1 .

Assignees

Inventors

Classifications

  • Animal cells · CPC title

  • C07K16/18Primary

    against material from animals or humans · CPC title

  • Stem cells · CPC title

  • involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)} · CPC title

  • Chemical aspects of mass spectrometric analysis of biological material · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11760792B2 cover?
The present invention relates to a GRP78-derived peptide for screening highly efficient stem cells and the use thereof, and more particularly, to screening highly efficient stem cells using, as a marker, a GRP78-derived peptide capable of binding to the binding domain of GRP78 protein on the cell surface. According to the present invention, the GRP78-derived peptide comprising only a specific a…
Who is the assignee on this patent?
Nibec Co Ltd, Nat Univ Chungbuk Ind Acad Coop Found, Seoul Nat Univ R&Db Foundation
What technology area does this patent fall under?
Primary CPC classification G01N33/56966. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).